Is Adeshwar Meditex overvalued or undervalued?

As of 20 October 2025, the valuation grade for Adeshwar Meditex has moved from expensive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE Ratio of 12.55, an EV to EBITDA of 8.15, and a Price to Book Value of 0.70, which indicate a reasonable valuation compared to its peers.
In comparison to its peers, Adeshwar Meditex's PE Ratio is significantly lower than that of Poly Medicure, which stands at 53.33, and Blue Jet Health at 31.97, both categorized as very expensive. The PEG Ratio of Adeshwar Meditex is 4.20, which is higher than some peers but still reflects a fair valuation in the current market context. Notably, the company's stock has underperformed against the Sensex over the past year, with a return of -18.18% compared to the Sensex's 3.86%, reinforcing the perspective that the stock is currently fairly valued.